Drug firm Zydus Cadila on Wednesday said it has commenced supplies of its COVID-19 vaccine ZyCoV-D to the central government. Photograph: Kind courtesy Zydus Cadila The company has initiated the......
Zydus Cadila's COVID-19 vaccine ZyCoV-D will initially be used in seven states, including Maharashtra, Tamil Nadu, Uttar Pradesh and West Bengal, which have been recommended to identify the......
Zydus Cadila has agreed to bring down the price of its COVID-19 vaccine to Rs 265 a dose following persistent negotiations by the government but a final deal is yet to be reached, sources said on......
With talks underway between the central government and Zydus Cadila over the pricing of the COVID-19 vaccine ZyCov-D, the pharma company is learnt to have proposed a price of Rs 1,900 for its......
Drug firm Zydus Cadila on Thursday said it has applied for emergency use authorisation (EUA) with the Indian drug regulator for its three-dose COVID-19 vaccine ZyCoV-D, and plans to manufacture......
Zydus Cadila Healthcare Ltd on Tuesday said it has received approval from the French regulatory agency, AFSSAPS, to market Sertraline capsules 25 mg and 50 mg, in the French market.Sertraline is an......
Zydus Cadila has tied up with France's second largest pharmacy network company Evolupharm to strengthen its presence in the euro1.5 billion French generics market. Evolupharm, which is the second......
Pharma major Zydus Cadila on Thursday entered into an agreement with Mayne Pharma of Australia to set up a 50:50 joint venture company to manufacture generic injectible cytotoxic (anti-cancer)......
Cadila Healthcare Ltd has announced that Zydus Cadila has received its very first approval from USFDA to market Atenolol, an anti-hypertensive drug, in the US market. Following this, the group......
Zydus Cadila Healthcare on Monday said its net profit during 2003-04 increased by 86.68 per cent to Rs 143 crore (Rs 1,430 million) as against Rs 76.6 crore (Rs 766 million) in the previous......